BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1554868)

  • 1. Possible mechanisms of the protective effect of pretreatment with anipamil in ischemic-reperfused isolated rat hearts.
    Kirkels JH; Ruigrok TJ; van Echteld CJ; Ceconi C; Ferrari R
    Cardioscience; 1992 Mar; 3(1):27-34. PubMed ID: 1554868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pretreatment with anipamil on a submaximal calcium paradox in the isolated rat heart.
    Ruigrok TJ; Kirkels JH
    Cardioscience; 1990 Sep; 1(3):213-6. PubMed ID: 2102810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of pretreatment with the calcium antagonist anipamil on the ischemic-reperfused rat myocardium: a phosphorus-31 nuclear magnetic resonance study.
    Kirkels JH; Ruigrok TJ; Van Echteld CJ; Meijler FL
    J Am Coll Cardiol; 1988 May; 11(5):1087-93. PubMed ID: 3356827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart.
    Hearse DJ; Ferrari R; Sutherland FJ
    J Mol Cell Cardiol; 1999 Nov; 31(11):1961-73. PubMed ID: 10591023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of the potent Na/H exchange inhibitor methylisobutyl amiloride against post-ischemic contractile dysfunction in rat and guinea-pig hearts.
    Moffat MP; Karmazyn M
    J Mol Cell Cardiol; 1993 Aug; 25(8):959-71. PubMed ID: 8263964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts.
    Ramasamy R; Hwang YC; Liu Y; Son NH; Ma N; Parkinson J; Sciacca R; Albala A; Edwards N; Szabolcs MJ; Cannon PJ
    Circulation; 2004 Apr; 109(13):1668-73. PubMed ID: 15051645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hypercarbic acidotic reperfusion on recovery of myocardial function after cardioplegic ischemia in neonatal lambs.
    Nomura F; Aoki M; Forbess JM; Mayer JE
    Circulation; 1994 Nov; 90(5 Pt 2):II321-7. PubMed ID: 7955274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of ischemia/reperfusion injury in isolated rats hearts by the ATP-sensitive potassium channel opener BMS-180448.
    Monticello TM; Sargent CA; McGill JR; Barton DS; Grover GJ
    Cardiovasc Res; 1996 Jan; 31(1):93-101. PubMed ID: 8849593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertonic perfusion reduced myocardial injury during subsequent ischemia and reperfusion in normal and hypertensive rats.
    Chen LB; Liu T; Wu JX; Chen XF; Wang L; Fan CL; Gao PJ; Higashino H; Lee WH; Yuan WJ; Chen H
    Acta Pharmacol Sin; 2003 Nov; 24(11):1077-82. PubMed ID: 14627488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of gallopamil against ischemia and reperfusion damage.
    Ferrari R; Boraso A; Condorelli E; De Giuli F; Pasini E; Cargnoni A; Agnoletti G; Ghielmi S
    Z Kardiol; 1989; 78 Suppl 5():1-11. PubMed ID: 2631474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.
    Feng NC; Satoh H; Urushida T; Katoh H; Terada H; Watanabe Y; Hayashi H
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):263-70. PubMed ID: 16495765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium overload during reperfusion is accelerated in isolated hypertrophied rat hearts.
    Allard MF; Flint JD; English JC; Henning SL; Salamanca MC; Kamimura CT; English DR
    J Mol Cell Cardiol; 1994 Dec; 26(12):1551-63. PubMed ID: 7731050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of calcium antagonists on energy and substrate metabolism during ischemia and reperfusion in hypertensive myocardial hypertrophy.
    Buser PT; Wagner S; Wu S; Higgins CB; Wikman-Coffelt J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S87-92. PubMed ID: 1725012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional recovery of post-ischemic myocardium requires glycolysis during early reperfusion.
    Jeremy RW; Ambrosio G; Pike MM; Jacobus WE; Becker LC
    J Mol Cell Cardiol; 1993 Mar; 25(3):261-76. PubMed ID: 8510169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of temperature on metabolic and cellular protection of the heart during long-term ischemia: a study using P-31 magnetic resonance spectroscopy and biochemical analyses.
    Bernard M; Cartoux C; Caus T; Sciaky M; Cozzone PJ
    Cryobiology; 1998 Dec; 37(4):309-17. PubMed ID: 9917347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the effects of Na+-H+ exchange inhibitors on cardiac function and apoptosis in guinea-pig ischemia-reperfused hearts.
    Hotta Y; Nishimaki H; Takeo T; Itoh G; Yajima M; Otsuka-Murakami H; Ishikawa N; Kawai N; Huang L; Yamada K; Yamamoto S; Matsui K; Ohashi N
    Eur J Pharmacol; 2004 Oct; 503(1-3):109-22. PubMed ID: 15496305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of quinidine on post-ischemic contractile failure of isolated rat hearts.
    Liu JX; Tanonaka K; Sanbe A; Yamamoto K; Takeo S
    J Mol Cell Cardiol; 1993 Oct; 25(10):1249-63. PubMed ID: 8263956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental study of intermittent crossclamping with fibrillation and myocardial protection: reduced injury from shorter cumulative ischemia or intrinsic protective effect?
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):528-37. PubMed ID: 10962415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.